Cellerix on track with perianal fistula treatment
This article was originally published in Scrip
Executive Summary
The Spanish biopharmaceutical company Cellerix is on schedule for the 2011 launch of its perianal fistula treatment, Ontaril, which uses stem cells isolated from the patient's own adipose tissue.